Picture of GSK logo

GSK GSK News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

REG - GlaxoSmithKline PLC - Director/PDMR Shareholding

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220223:nRSW6074Ca&default-theme=true

RNS Number : 6074C  GlaxoSmithKline PLC  23 February 2022

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

 1.  Details of PDMR/person closely associated with them ('PCA')
 a)  Name                                     Ms V Whyte
 b)  Position/status                          Company Secretary
 c)  Initial notification/                    Initial Notification

     amendment
 2.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     GlaxoSmithKline plc
 b)  LEI                                      5493000HZTVUYLO1D793
 3.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transaction(s) has been conducted
 a)  Description of the financial instrument  Ordinary shares of 25 pence each ('Ordinary Shares')

                                              ISIN: GB0009252882

 b)  Nature of the transaction                Transfer of 11,170 Ordinary Shares between accounts for nil consideration.

 c)  Price(s) and volume(s)                                        Price(s)             Volume(s)
                                                                   £0.00                11,170

 d)  Aggregated information                   N/A (single transaction)
     Aggregated volume Price
 e)  Date of the transaction                  2022-02-18
 f)  Place of the transaction                 N/A

 

 

 1.  Details of PDMR/person closely associated with them ('PCA')
 a)  Name                                     Ms V Whyte
 b)  Position/status                          Company Secretary
 c)  Initial notification/                    Initial Notification

     amendment
 2.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     GlaxoSmithKline plc
 b)  LEI                                      5493000HZTVUYLO1D793
 3.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transaction(s) has been conducted
 a)  Description of the financial instrument  Ordinary shares of 25 pence each ('Ordinary Shares')

                                              ISIN: GB0009252882

 b)  Nature of the transaction                Transfer of 11,344 Ordinary Shares to spouse for nil consideration.

 c)  Price(s) and volume(s)                                      Price(s)           Volume(s)
                                                                 £0.00              11,344

 d)  Aggregated information                   N/A (single transaction)
     Aggregated volume Price
 e)  Date of the transaction                  2022-02-23
 f)  Place of the transaction                 N/A

 

 

     Details of PDMR/person closely associated with them ('PCA')
 a)  Name                                       Mr I Whyte
 b)  Position/status                            PCA of Ms V Whyte (Company Secretary)
 c)  Initial notification/                      Initial Notification

     amendment
 2.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                       GlaxoSmithKline plc
 b)  LEI                                        5493000HZTVUYLO1D793
 3.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transaction(s) has been conducted
 a)  Description of the financial  instrument   Ordinary shares of 25 pence each ('Ordinary Shares')

                                                ISIN: GB0009252882

 b)  Nature of the transaction                  Receipt of 11,344 Ordinary Shares from spouse for nil consideration.
 c)  Price(s) and volume(s)                                         Price(s)            Volume(s)
                                                                    £0.00               11,344

 d)  Aggregated information                     N/A (single transaction)
     Aggregated volume Price
 e)  Date of the transaction                    2022-02-23
 f)  Place of the transaction                   N/A

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHZXLFLLLLZBBB

Recent news on GSK

See all news